rivastigmine 1 a pharma
1 a pharma gmbh - rivastigmine - alzheimer disease; dementia; parkinson disease - psychoanaleptics, - simptomātiska vieglas vai vidēji smaga alcheimera demences ārstēšana. simptomātiska ārstēšana vieglas vai vidēji smagas demences pacientiem ar idiopātisko parkinsona slimība.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiski līdzekļi - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
abiraterone g.l. pharma 500 mg apvalkotās tabletes
g.l. pharma gmbh, austria - abirateroni acetas - apvalkotā tablete - 500 mg
prenewel 4 mg/1,25 mg tabletes
krka, d.d., novo mesto, slovenia - tert-butylamini perindoprilum, indapamidum - tablete - 4 mg/1,25 mg
prenewel 8 mg/2,5 mg tabletes
krka, d.d., novo mesto, slovenia - tert-butylamini perindoprilum, indapamidum - tablete - 8 mg/2,5 mg
prenewel 2 mg/0,625 mg tabletes
krka, d.d., novo mesto, slovenia - tert-butylamini perindoprilum, indapamidum - tablete - 2 mg/0,625 mg
renewal (paziņots 2011.) kapsula
alina farma, sia - kapsula
new earth sēņu ekstraktu komplekss (2024.) kapsula
kapsula
new earth cordyceps (2024.) kapsula
kapsula
new earth reishi (2024.) kapsula
kapsula